Cogent Biosciences宣佈在胃腸道間質瘤（GIST）患者中進行的3期峯試驗已

快訊 · 09/03 20:03

Cogent Biosciences Announces Phase 3 Peak Trial in Patients With Gastrointestinal Stromal Tumors (Gist) Has Completed Enrollment and Advanced Past Interim Futility Analysis

Cogent Biosciences宣佈在胃腸道間質瘤（GIST）患者中進行的3期峯試驗已完成招募並完成中期無效分析。